Retroviruses and Reverse Transcription

MCAT trap: Reverses the direction of reverse transcription (DNA→RNA instead of RNA→DNA). Reverse transcriptase converts the viral RNA genome into double-stranded DNA, which is then integrated into the host genome.

Retroviruses are a non-negotiable MCAT topic — HIV is the canonical example, and the exam tests the life cycle at every level. Two misconceptions come up constantly: students reverse the direction of reverse transcriptase (it goes RNA→DNA, not DNA→RNA), and they argue that retroviruses 'violate' the central dogma. They don't. Retroviruses add an RNA→DNA step, then proceed with normal transcription and translation from proviral DNA — that's an extension of the central dogma, not a violation. Reverse transcriptase converts the viral RNA genome into double-stranded DNA, which integrase then inserts into the host chromosome, where it can persist indefinitely and be transcribed like a normal host gene.

The MCAT tests retroviruses at multiple levels. At the recall level, you need the sequence: viral RNA → reverse transcriptase → dsDNA → integrase → host genome → transcription → translation → new virions. At the application level, expect passage-based questions where you have to identify which step a given drug targets or predict what happens if a specific enzyme is inhibited. The central dogma connection is the highest-yield conceptual angle — the exam loves asking whether retroviruses 'violate' the central dogma, which requires you to understand what the central dogma actually says.

The trickiest part is keeping the enzymes straight and understanding exactly what each one does. Students routinely flip the direction of reverse transcription (thinking it goes DNA→RNA) or blur reverse transcriptase and integrase into a single vague 'insertion enzyme.' The central dogma misconception is also common: retroviruses don't skip DNA — they make DNA from RNA before proceeding with normal transcription and translation. That's an extension of the central dogma, not a violation of it.

Common misconceptions

Common mistake

Wrong: Reverse transcriptase converts host DNA into viral RNA.

Right: Reverse transcriptase converts the viral RNA genome into double-stranded DNA, which is then integrated into the host genome.

The name 'reverse transcriptase' signals the direction: it's the reverse of normal transcription, which goes DNA→RNA. So reverse transcriptase goes RNA→DNA, not DNA→RNA. The viral RNA genome is the template, and the product is double-stranded DNA. If you catch yourself thinking the enzyme reads host DNA to make viral RNA, you've flipped the whole point of the enzyme.

Common mistake

Wrong: Retroviruses violate the central dogma because they make protein directly from RNA without DNA.

Right: Retroviruses extend the central dogma by adding an RNA→DNA step (reverse transcription); they do not bypass DNA—they create it from RNA before transcription and translation proceed normally.

The central dogma says information flows DNA→RNA→protein; it does not say RNA→DNA is impossible. Retroviruses add that RNA→DNA step (reverse transcription), but after that, the integrated proviral DNA is transcribed and translated completely normally. There is no bypass of DNA — in fact, a stable DNA intermediate is required. This is an extension or amendment of the central dogma, not a violation.

Common mistake

Wrong: Reverse transcriptase is responsible for inserting viral DNA into the host chromosome.

Right: Reverse transcriptase synthesizes dsDNA from viral RNA; integrase is the distinct enzyme that catalyzes insertion of the viral dsDNA into the host genome.

These are two distinct enzymes with two distinct jobs. Reverse transcriptase synthesizes dsDNA from the viral RNA template — its job ends once dsDNA is made. Integrase then takes over and catalyzes the insertion of that dsDNA into the host chromosome. On the MCAT, this distinction matters because integrase inhibitors (like raltegravir) are a separate drug class from reverse transcriptase inhibitors (NRTIs, NNRTIs).

Common mistake

Gap: Cannot map antiretroviral drug classes to their specific steps in the HIV life cycle

Major antiretroviral drug targets in HIV include reverse transcriptase (NRTIs, NNRTIs), integrase (integrase inhibitors), protease (protease inhibitors), and viral entry/fusion (fusion inhibitors, CCR5 antagonists).

Map each drug class to its step in the HIV life cycle: fusion inhibitors and CCR5 antagonists block viral entry before the virus even gets inside; NRTIs and NNRTIs inhibit reverse transcriptase during the RNA→DNA conversion step; integrase inhibitors block insertion of viral dsDNA into the host genome; and protease inhibitors prevent maturation of new virions by blocking cleavage of viral polyproteins after budding. If a passage describes inhibiting a specific step, you need to instantly know which drug class fits.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Understand the mechanism of reverse transcription: reverse transcriptase uses the viral RNA genome as a template to synthesize double-stranded DNA, and then integrase (a separate enzyme) inserts that dsDNA into the host chromosome.
Know the HIV life cycle from entry to budding, and be able to identify which specific step each class of antiretroviral drug (NRTIs, NNRTIs, integrase inhibitors, protease inhibitors, fusion inhibitors, CCR5 antagonists) targets.
Explain how retroviruses relate to the central dogma: they add an RNA→DNA information flow step (reverse transcription) that extends the central dogma rather than violating or bypassing it — transcription and translation still proceed normally from the proviral DNA.

Can you avoid these mistakes?

Walk through the HIV life cycle in order from binding to the host cell to release of new virions. For each major step, name the enzyme or viral component responsible — and for at least three steps, name the drug class that targets it.

A researcher develops a compound that prevents viral RNA from being converted into DNA inside infected cells. Which HIV enzyme is this compound targeting, and at what step in the life cycle does it act? How would this differ from a compound that prevents newly made viral DNA from being inserted into the host chromosome?

A classmate argues that HIV 'violates the central dogma' because it's an RNA virus that replicates inside cells. Do you agree? Explain specifically what the central dogma states, what retroviruses actually do, and why 'extension' is more accurate than 'violation.'

If a patient's HIV treatment regimen includes a protease inhibitor, what happens to the virus if the protease is successfully inhibited? Would you expect viral RNA to still be made? Would new virions still bud from the cell? Why or why not?

Retroviruses and Reverse Transcription

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics